Premium & Rewards Members 25% Off Pre-Order Books With Code PREORDER25 Ends 6/26 Shop Now Online only. See page for details.Premium & Rewards Members 25% Off Pre-Order Books With Code PREORDER25 Ends 6/26 Shop Now Online only. See page for details.
Add Item to wish listAdd Item to wish list

Exact Sciences Corporation (Strategic Valuation, #1)

By Strategic Valuation
eBook
$9.95
By Strategic Valuation
Membership Card Icon
Collect stamps to save with Rewards. 10 stamps = $5. Learn More
Formats
Select a store to view item availability.

Available on compatible , the free NOOK App, and in My Digital Library

NOOK App

Download NOOK app

NOOK Devices

NOOK eReaders

  • NOOK GlowLight 4 Plus
  • NOOK GlowLight 4e
  • NOOK GlowLight 4
  • NOOK GlowLight Plus 7.8"
  • NOOK GlowLight 3
  • NOOK GlowLight Plus 6"

NOOK Tablets

  • NOOK 9" Lenovo Tablet
  • NOOK 10" HD Lenovo Tablet
  • NOOK Tablet 7" & 10.1"
  • NOOK by Samsung Galaxy Tab 7.0 [Tab A and Tab 4]
  • NOOK by Samsung [Tab 4 10.1, S2 & E]

Free NOOK Reading Apps

  • NOOK for iOS
  • NOOK for Android

BN.com website

Go to your Digital Library in My Account

Limit 1 per customer

Exact Sciences Corporation (EXAS) is a publicly traded molecular diagnostics company focused on the early detection and prevention of colon cancer. EXAS has developed, and currently commercializes the Cologuard test, a non-invasive stool-based deoxyribonucleic acid screening test designed to detect DNA markers for colorectal cancer.

At the end of 2015, Cologuard's first full year on the market, EXAS completed 104,000 tests from 27,000 ordering physicians and realized revenue of $39 million. ...

Categories

Professional Finance & InvestingCorporate FinanceCorporate ValuationCorporations->Valuation->General